No abstract available
MeSH terms
-
Cardiovascular Diseases / prevention & control*
-
Data Interpretation, Statistical
-
Fluorobenzenes / adverse effects
-
Fluorobenzenes / therapeutic use*
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Kidney Failure, Chronic / blood
-
Kidney Failure, Chronic / drug therapy*
-
Kidney Failure, Chronic / mortality
-
Lipids / blood
-
Patient Dropouts / statistics & numerical data
-
Patient Selection
-
Pyrimidines / adverse effects
-
Pyrimidines / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Renal Dialysis / adverse effects*
-
Research Design
-
Risk
-
Rosuvastatin Calcium
-
Sulfonamides / adverse effects
-
Sulfonamides / therapeutic use*
-
Uremia / blood
-
Uremia / drug therapy*
-
Uremia / mortality
Substances
-
Fluorobenzenes
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Lipids
-
Pyrimidines
-
Sulfonamides
-
Rosuvastatin Calcium